{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:12:54Z","timestamp":1790633574466,"version":"4.1.0"},"reference-count":32,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Antithyroid drug (ATD) therapy in early pregnancy is associated with birth defects, but more data are needed to substantiate the risk associated with different types of ATD. Furthermore, the role of abnormal maternal thyroid function per se remains unclarified.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the risk of birth defects associated with the use of ATD in an extended nationwide cohort and the role of abnormal maternal thyroid function in birth cohorts including stored maternal blood samples from early pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Danish pregnant women and their live-born children, including 1,243,353 children from a Nationwide Register-Based Cohort (NRBC), 1997 to 2016; 8830 children from the Danish National Birth Cohort (DNBC), 1997 to 2003; and 14,483 children from the North Denmark Region Pregnancy Cohort (NDRPC), 2011 to 2015.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Birth defects diagnosed before 2 years of age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the NRBC, altogether 2718 (0.2%) children had been exposed to ATD in early pregnancy. The overall frequency of birth defects was 6.7% (95% CI, 6.7% to 6.8%) in nonexposed children and higher after exposure to methimazole\/carbimazole (9.6%; 95% CI, 8.2% to 11.2%) and propylthiouracil (8.3%; 95% CI, 6.7% to 10.3%). On the other hand, the frequency of maternal thyroid dysfunction in early pregnancy was similar in the random cohort and in cases of birth defect in the DNBC (12.4 vs 12.6%, P = 0.8) and the NDRPC (15.1 vs 15.4%, P = 0.8).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Results corroborate an increased risk of birth defects associated with the use of ATD in early pregnancy and suggest that abnormal maternal thyroid function is not a major risk factor for birth defects.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jc.2019-01343","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T09:05:14Z","timestamp":1565687114000},"page":"6040-6048","source":"Crossref","is-referenced-by-count":46,"title":["Maternal Thyroid Function, Use of Antithyroid Drugs in Early Pregnancy, and Birth Defects"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6336-1936","authenticated-orcid":false,"given":"Stine Linding","family":"Andersen","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6311-6727","authenticated-orcid":false,"given":"Louise","family":"Kn\u00f8sgaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"},{"name":"Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark"},{"name":"Steno Diabetes Center North Jutland, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Andersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"},{"name":"Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"issue":"10","key":"2019103013342980700_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"3","key":"2019103013342980700_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"issue":"3","key":"2019103013342980700_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","article-title":"Hyperthyroidism in pregnancy","volume":"1","author":"Cooper","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"2019103013342980700_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MED.0000000000000353","article-title":"Risk of embryopathies with use of antithyroidal medications","volume":"24","author":"Andersen","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"11","key":"2019103013342980700_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/thy.2015.0182","article-title":"Antithyroid drug use in pregnancy and birth defects: why some studies find clear associations, and some studies report none","volume":"25","author":"Laurberg","year":"2015","journal-title":"Thyroid"},{"issue":"7","key":"2019103013342980700_bib6","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of Graves\u2019 disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2019103013342980700_bib7","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"Andersen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2019103013342980700_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/M17-1398","article-title":"Antithyroid drugs and congenital malformations: a nationwide Korean cohort study","volume":"168","author":"Seo","year":"2018","journal-title":"Ann Intern Med"},{"issue":"4","key":"2019103013342980700_bib9","doi-asserted-by":"crossref","first-page":"e35213","DOI":"10.1371\/journal.pone.0035213","article-title":"Propylthiouracil is teratogenic in murine embryos","volume":"7","author":"Benavides","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2019103013342980700_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1096\/fj.12-218073","article-title":"Embryonic exposure to propylthiouracil disrupts left-right patterning in Xenopus embryos","volume":"27","author":"van Veenendaal","year":"2013","journal-title":"FASEB J"},{"issue":"4","key":"2019103013342980700_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/bdrb.21113","article-title":"Evaluation of developmental toxicity of propylthiouracil and methimazole","volume":"101","author":"Mallela","year":"2014","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"3","key":"2019103013342980700_bib12","first-page":"320","article-title":"The Danish medical birth registry","volume":"45","author":"Knudsen","year":"1998","journal-title":"Dan Med Bull"},{"issue":"7","key":"2019103013342980700_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry","volume":"39","author":"Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"issue":"6","key":"2019103013342980700_bib14","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1210\/jc.2016-1387","article-title":"Dynamics and predictors of serum TSH and fT4 reference limits in early pregnancy: a study within the Danish National Birth Cohort","volume":"101","author":"Laurberg","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019103013342980700_bib15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1089\/thy.2018.0628","article-title":"Pregnancy week-specific reference ranges for thyrotropin and free thyroxine in the North Denmark Region Pregnancy Cohort","volume":"29","author":"Andersen","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"2019103013342980700_bib16","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences","volume":"46","author":"Andersen","year":"1999","journal-title":"Dan Med Bull"},{"issue":"4","key":"2019103013342980700_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/thy.2017.0425","article-title":"Maternal thyroid function in early pregnancy and child neurodevelopmental disorders: a Danish nationwide case-cohort study","volume":"28","author":"Andersen","year":"2018","journal-title":"Thyroid"},{"issue":"5","key":"2019103013342980700_bib18","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1530\/EJE-18-0678","article-title":"Anniversary review: antithyroid drug therapy: 70 years later","volume":"179","author":"Burch","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019103013342980700_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/tera.1420050117","article-title":"Maternal methimazole and congenital defects in children","volume":"5","author":"Milham","year":"1972","journal-title":"Teratology"},{"issue":"11","key":"2019103013342980700_bib20","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1471-0528.2011.03019.x","article-title":"Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study","volume":"118","author":"Chen","year":"2011","journal-title":"BJOG"},{"issue":"6","key":"2019103013342980700_bib21","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/thy.2012.0488","article-title":"Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States","volume":"23","author":"Korelitz","year":"2013","journal-title":"Thyroid"},{"issue":"6","key":"2019103013342980700_bib22","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1089\/thy.2014.0434","article-title":"Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system","volume":"25","author":"Lo","year":"2015","journal-title":"Thyroid"},{"issue":"9","key":"2019103013342980700_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s40618-015-0281-z","article-title":"Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy","volume":"38","author":"Gianetti","year":"2015","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2019103013342980700_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/EJE-17-0314","article-title":"Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study","volume":"177","author":"Andersen","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2019103013342980700_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-8628(19990305)83:1<43::AID-AJMG8>3.0.CO;2-C","article-title":"Methimazole embryopathy: delineation of the phenotype","volume":"83","author":"Clementi","year":"1999","journal-title":"Am J Med Genet"},{"issue":"2","key":"2019103013342980700_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.30418","article-title":"Carbimazole embryopathy: an emerging phenotype","volume":"132A","author":"Foulds","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"10","key":"2019103013342980700_bib27","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/thy.2014.0150","article-title":"Severity of birth defects after propylthiouracil exposure in early pregnancy","volume":"24","author":"Andersen","year":"2014","journal-title":"Thyroid"},{"issue":"1","key":"2019103013342980700_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/thy.2018.0621","article-title":"Timing of shift in antithyroid drug therapy and birth defects","volume":"29","author":"Andersen","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"2019103013342980700_bib29","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-14-0135","article-title":"Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk","volume":"171","author":"Laurberg","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2019103013342980700_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2265.1984.tb00119.x","article-title":"Maternal hyperthyroidism and congenital malformation in the offspring","volume":"20","author":"Momotani","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019103013342980700_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2003-38320","article-title":"Gastrointestinal malformations in two infants born to women with hyperthyroidism untreated in the first trimester","volume":"20","author":"Seoud","year":"2003","journal-title":"Am J Perinatol"},{"issue":"7","key":"2019103013342980700_bib32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1017\/S1047951114001887","article-title":"Maternal hypothyroidism may be associated with CHD in offspring","volume":"25","author":"Grattan","year":"2015","journal-title":"Cardiol Young"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/jc.2019-01343\/29153112\/jc.2019-01343.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/12\/6040\/30312385\/jc.2019-01343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/12\/6040\/30312385\/jc.2019-01343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T14:23:11Z","timestamp":1572445391000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/12\/6040\/5548919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-01343","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,8,13]]}}}